Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Galapagos NV ADR
(NQ:
GLPG
)
29.45
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
16,237
Open
29.45
Bid (Size)
29.26 (5)
Ask (Size)
29.36 (5)
Prev. Close
29.45
Today's Range
29.45 - 29.45
52wk Range
28.82 - 44.25
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst
April 01, 2024
BofA Securities downgrades Galapagos to underperform due to limited near-term catalysts and competitive challenges in crowded markets.
Via
Benzinga
Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline
February 22, 2024
From
Frontier Medicines
Via
GlobeNewswire
Performance
YTD
-28.76%
-28.76%
1 Month
-9.88%
-9.88%
3 Month
-22.89%
-22.89%
6 Month
-12.66%
-12.66%
1 Year
-23.94%
-23.94%
More News
Read More
European Drugmaker Galapagos Collaborates With Biotech BridGene Biosciences To Develop Cancer Treatments
January 03, 2024
Via
Benzinga
GLPG Stock Earnings: Galapagos Beats EPS, Beats Revenue for Q3 2023
December 13, 2023
Via
InvestorPlace
8 Analysts Have This to Say About Galapagos
July 17, 2023
Via
Benzinga
Where Galapagos Stands With Analysts
June 12, 2023
Via
Benzinga
JP Morgan Maintains Neutral Rating for Galapagos: Here's What You Need To Know
May 31, 2023
Via
Benzinga
Earnings Outlook For Galapagos
May 03, 2023
Via
Benzinga
Earnings Preview For Galapagos
February 23, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
May 08, 2023
Via
Benzinga
BigCommerce, ContextLogic And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 24, 2023
Via
Benzinga
Galapagos' Blood Cancer Candidate Shows 100% Objective Response Rate In Relapsed/Refractory Patients
February 10, 2023
Via
Benzinga
Where Galapagos Stands With Analysts
November 07, 2022
Via
Benzinga
Where Galapagos Stands With Analysts
September 09, 2022
Via
Benzinga
Why Galapagos Stock Is Falling Today
February 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
January 23, 2023
Via
Benzinga
Twitter Rolls Out 'Blue For Business,' Visa Pitches Auto-Payments On Ethereum Blockchain, Justin Bieber Slams H&M: Today's Top Stories
December 20, 2022
Via
Benzinga
On A Mission As Top European Player, Galapagos Looks For Acquisition Targets
December 20, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022
November 07, 2022
Via
Benzinga
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
October 31, 2022
Via
Benzinga
Expert Ratings for Galapagos
October 13, 2022
Via
Benzinga
3 Biotech Stocks to Sell in October
September 29, 2022
Via
InvestorPlace
Lyft, DoorDash, Expedia And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
August 05, 2022
Via
Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.